BA.2.86
SARS-CoV-2 Omicron BA.2.86
BA.2.86 represents a highly divergent Omicron subvariant with numerous spike protein mutations.
Quick Facts
Transmissibility
Moderate transmissibility
Vaccine Evasion
Significant antigenic change from XBB variants
Global Prevalence
Low but persistent circulation
Symptoms & Signs
Common Symptoms
Distinctive Features
Prevention & Treatment
Prevention Strategies
Treatment Options
Standard COVID-19 treatments remain effective
Key Mutations
30+ mutations in spike protein
Global Surveillance
Key Research Findings
Extensive mutations raised initial concern
Lower transmissibility than initially feared
Parent lineage to more successful JN.1
Important for vaccine strain selection
High-Risk Groups
Related Variants
Omicron BA.5
BA.5 was the dominant Omicron subvariant during summer 2022, characterized by increased transmissibi...
Omicron XBB
XBB is a recombinant variant combining genetic material from two BA.2 sublineages, showing enhanced ...
JN.1
JN.1 emerged as a descendant of BA.2.86 with additional mutations conferring transmission advantages...
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult with qualified healthcare providers for diagnosis, treatment, and medical guidance. Information last updated: 2025-06-20.